ferric carboxymaltose solution
Term · Oncology and biomedicine · MLC-T-ONC-013565
A parenteral iron solution containing ferric iron complexed with carboxymaltose polymers, used in parenteral iron-replacement therapy. Upon administration, ferric carboxymaltose is removed from plasma by the reticuloendothelial system. Subsequently, ferric iron binds to transferrin or is stored as ferritin. Transferrin-bound iron is transported in the plasma to the liver, spleen and bone marrow, where it is incorporated into hemoglobin, and to muscle, where it is incorporated into myoglobin.
| Identifier | MLC-T-ONC-013565 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | FCM |
| Synonyms | ferric carboxymaltose injection |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013565",
"term": "ferric carboxymaltose solution",
"field": "Oncology and biomedicine",
"definition": "A parenteral iron solution containing ferric iron complexed with carboxymaltose polymers, used in parenteral iron-replacement therapy. Upon administration, ferric carboxymaltose is removed from plasma by the reticuloendothelial system. Subsequently, ferric iron binds to transferrin or is stored as ferritin. Transferrin-bound iron is transported in the plasma to the liver, spleen and bone marrow, where it is incorporated into hemoglobin, and to muscle, where it is incorporated into myoglobin.",
"abbreviation": "FCM",
"synonyms": [
"ferric carboxymaltose injection"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/ferric-carboxymaltose-solution/"
}
Record 7,222 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.